Delpharm Overview

  • Year Founded
  • 1988

Year Founded

  • Status
  • Private

  • Employees
  • 6,500


  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 11

  • Investments
  • 14

Delpharm General Information


Manufacturer of pharmaceutical products intended to serve the healthcare sector. The company's offerings include tablets, pills, film-coated tablets, granulates, pouches, capsules and veterinary products, thereby enabling clients with one-stop assistance for the development, production and packaging of pharmaceutical products.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Corporate Office
  • DELRIV Port de Boulogne-Billancourt
  • In front of 9 quai du 4 Septembre
  • 92100 Boulogne-Billancourt
  • France
+33 01 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Delpharm Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Delpharm‘s full profile, request access.

Request a free trial

Delpharm Executive Team (10)

Name Title Board Seat
Sebastien Aguettant Chief Executive Officer, President & Chairman
Charles Gaudin Chief Financial Officer
Nicolas Leforestier Chief Operating Officer
Nicolas Ragot Managing Director
Olivier Lavictoire Chief Human Resources Officer
You’re viewing 5 of 10 executive team members. Get the full list »

Delpharm Board Members (1)

Name Representing Role Since
000000 00000000 Delpharm Board Member 000 0000
To view Delpharm’s complete board members history, request access »

Delpharm Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Delpharm Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Delpharm‘s full profile, request access.

Request a free trial

Delpharm Investments & Acquisitions (14)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Astellas Pharma (Manufacturing Business in Meppel, Netherlands) 31-Dec-2023 0000000000 Pharmaceuticals 000000000
Carelide 17-Feb-2023 0000000000 Pharmaceuticals
Dr. Reddy's Research and Development 17-Dec-2022 0000000000 Pharmaceuticals
Novartis (Sterile Injectable Drug Manufacturing Facility in Boucherville, Canada) 01-Mar-2022 000000000 Buildings and Property 000000000
GlaxoSmithKline (Drug Manufacturing Plant in Poznan) 15-Oct-2021 Corporate Asset Purchase Buildings and Property
You’re viewing 5 of 14 investments and acquisitions. Get the full list »

Delpharm Subsidiaries (2)

Company Name Industry Location Founded
Delpharm Development Leiden Pharmaceuticals Bladel, Netherlands 2022
Carelide Pharmaceuticals Mouvaux, France 0000
To view Delpharm’s complete subsidiaries history, request access »

Delpharm FAQs

  • When was Delpharm founded?

    Delpharm was founded in 1988.

  • Who is the CEO of Delpharm?

    Sebastien Aguettant is the CEO of Delpharm.

  • Where is Delpharm headquartered?

    Delpharm is headquartered in Boulogne-Billancourt, France.

  • What is the size of Delpharm?

    Delpharm has 6,500 total employees.

  • What industry is Delpharm in?

    Delpharm’s primary industry is Pharmaceuticals.

  • Is Delpharm a private or public company?

    Delpharm is a Private company.

  • What is Delpharm’s current revenue?

    The current revenue for Delpharm is 00000.

  • Who are Delpharm’s investors?

    Capza has invested in Delpharm.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »